Page 2 of 10 – SEC Filing CUSIP NO.
1 Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Global Healthcare Master Fund, LP 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [x] 3 SEC Use Only 4 Citizenship or Place of Organization. Cayman Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 shares 6 Shared Voting Power 1,658,151 shares Refer to Item 4 below. 7 Sole Dispositive Power 0 shares 8 Shared Dispositive Power 1,658,151 shares Refer to Item 4 below. 9 Aggregate Amount Beneficially Owned by Each Reporting Person 1,658,151 shares Refer to Item 4 below. 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A 11 Percent of Class Represented by Amount in Row (9)* 8.5% Refer to Item 4 below. 12 Type of Reporting Person (See Instructions) PN (Partnership)
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP NO. |
| 1 | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Cormorant Global Healthcare Master Fund, LP | |
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |
| (a) [ ] | ||
| (b) [x] | ||
| 3 | SEC Use Only | |
| 4 | Citizenship or Place of Organization. Cayman Islands | |
| Number of Shares Beneficially Owned by Each Reporting Person With | 5 Sole Voting Power 0 shares | |
| 6 Shared Voting Power 1,658,151 shares Refer to Item 4 below. | ||
| 7 Sole Dispositive Power 0 shares | ||
| 8 Shared Dispositive Power 1,658,151 shares Refer to Item 4 below. | ||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 1,658,151 shares Refer to Item 4 below. | |
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A | |
| 11 | Percent of Class Represented by Amount in Row (9)* 8.5% Refer to Item 4 below. | |
| 12 | Type of Reporting Person (See Instructions) PN (Partnership) | |
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Follow Clearside Biomedical Inc. (NASDAQ:CLSD)
Receive real-time insider trading and news alerts




